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Dear editors,
Ransing et al.1 recently summarized the current available instruments for assessing 
mental health issues relating to the COVID-19 pandemic in Brain, Behavior, and Immunity. 
Among the four instruments reviewed by Ransing et al.1 was the Fear of COVID-19 Scale 
(FCV-19S) that we co-developed and rated as having the most evidence in relation to its 
psychometric properties. While the Coronavirus Anxiety Scale (CAS)2 and the Obsession 
with COVID-19 Scale (OCS)3 both have versions in other languages, only have their English 
version has been psychometrically validated. Moreover, the COVID Stress Scale (CSS)4 has 
only been validated in English. However, the FCV-19S, as reviewed by Ransing et al.1, has 
been translated into different language versions and tested in different country populations. 
Ransing et al.1 recommend there is a need to translate, validate, and cultural-adapt the 
existing instruments. We would like to point out that the FCV-19S has already been validated 
in many languages with good psychometric properties including English5, Persian6, Bangla7, 
Italian8, Hebrew9, Arabic10, Russian11, and Turkish12). We are also aware that there are other 
versions currently under review including versions in Spanish, Japanese, Hindi, Malaysian, 
and Polish. To the best of our knowledge, these research teams have also found good 
psychometric properties for the FCV-19S. Therefore, we are confident that the FCV-19S has 
already fulfilled the recommendation made by Ransing et al.1 Moreover, the FCV-19S is 
arguably more theoretically grounded than other COVID-19-related instruments in that it was 
developed using the Protection Motivation Theory13, while the other three instruments do not 
report any theoretical framework to support their development.   
However, we would like to clarify the remarks made by Ransing et al.1 regarding the 
unstable factor structure of the FCV-19S (i.e., a two-factor structure found in the Russian 
FCV-19S11). In addition to the Russian version, the Hebrew FCV-19S9 also reported a two-
factor structure. However, we are of the opinion that the two-factor structure proposed by 
both the Russian and Hebrew versions are a consequence of their inappropriate use of 
principal component analysis (PCA) or exploratory factor analysis (EFA). Given that many 
language versions of the FCV-19S6-8,10,12 confirmed its unidimensional structure, the use of 
PCA or EFA is not justified because a confirmatory factor analysis (CFA) should have been 
performed.14 Only if the researchers have strong reasons to doubt the theoretical framework, 
should they have considered applying EFA for further understanding in an instrument’s factor 
structure. 
Ransing et al.1 also recommend validating the instruments among vulnerable 
populations, including elderly, children, adolescents, young adults, and people with pre-
existing physical and mental illness. We totally agree with the recommendation and would 
like to respond that we have already collected FCV-19S among individuals with mental 
illness, elderly people who have visited an outpatient department in a medical center, and 
adolescents. The collections were all face-to-face interviews and administered by several 
research assistants and online surveys. Those with mental illness (n=516; 294 males; mean 
age=47.5 years) were interviewed between March 23 and May 15, 2020 from the Jianan 
Psychiatric Center, Taiwan. Elderly individuals (n=139; 42 males; mean age=71.7) were 
interviewed between May 1 and 15, 2020 from the Wan Fang Hospital, Taiwan. The 
adolescents (n=582; 274 males; mean age=18.02 years) completed an online survey between 
March and April 2020 from a Bangla community7. Utilizing CFA with the estimator of 
diagonally weighted least squares, we found that the FCV-19S also supported the 
unidimensional structure in the three vulnerable samples (Table 1). Therefore, we believe that 
the FCV-19S can assess fear of COVID-19 among clinical and vulnerable samples. 
Nevertheless, we agree with the other future directions proposed by Ransing et al.1 regarding 
the need for the development of both clinically administered instruments and instruments 
assessing stigma15.
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Table 1. Factor structure of the Fear of COVID-19 Scale (FCV-19S) in three vulnerable 
samples
Mental illness Elderly Adolescent 
Item # Factor loading
F1 0.66 0.72 0.72
F2 0.81 0.54 0.66
F3 0.82 0.29 0.73
F4 0.82 0.65 0.77
F5 0.85 0.77 0.69
F6 0.82 0.46 0.64
F7 0.86 0.38 0.65
Fit statistics
χ2 (df)/ p 44.97 (14)/ <0.001 24.10 (14)/ 0.045 21.53 (14)/ 0.09
CFI 0.992 0.960 0.997
TLI 0.989 0.941 0.995
RMSEA 0.066 0.072 0.030
90% CI of RMSEA 0.045, 0.087 0.011, 0.120 0.000, 0.055
CFI=comparable fit index; TLI=Tucker-Lewis index; RMSEA=root mean square error of 
approximation. 
